"Heart"

Coronary heart disease is not terrible, reasonable medication is the key to a healthy life starting from the heart.

It is reported that researchers from Georgia Institute of Technology and Piemonte Heart Institute are using customized 3D printed heart valve models based on patients' heart CT scanning to improve the success rate of transcatheter aortic valve replacement (TAVR) surgery. Their aim is to avoid perivalvular leakage. This research has been published in JACC: Cardiovascular Imaging.

Relevant surveys show that the risk of heart attack will increase by 7% for every 10 ℃ drop in temperature. Experts pointed out that in cold weather, the human body should first ensure the blood supply of important organs such as the brain, heart, lung and liver, and the contraction of peripheral blood vessels such as skin. The increase of blood pressure and heart rate will increase the burden on the heart, which will easily lead to heart disease

Although immortality is still only a myth in the mirror, living a long and healthy life is a goal that most people seem to be able to achieve.

Heart failure is the abbreviation of heart failure. It is a group of complex clinical syndromes with ventricular filling or impaired ejection capacity. The main clinical manifestations are dyspnea, fatigue, and fluid retention. Heart failure is one of the five fatal cardiovascular diseases, with a high prevalence rate, high hospitalization times and heavy economic burden.

The continuous high temperature and hot weather in summer can not be ignored for people with cardiovascular diseases. Once they relax their vigilance, heart failure is very likely to occur, and heart failure is the end stage of various heart diseases, known as the stumbling block of life, which seriously endangers life and health.

The ultimate goal of treating diabetes is to reduce the occurrence of coronary heart disease.

The clinical trial (PARABLE) will take place at 22 sites across the UK and is planned to recruit 192 patients at higher risk of developing heart problems. the PARABLE trial is led by researchers from the Royal Marsden Hospital, the University of Cambridge, and the Institute of Cancer Research (ICR) UK, and is managed by the Clinical Trials and Statistics Unit, funded by Cancer Research UK, at the Institute of Cancer Research (ICR). was conducted.